Dermaclara reveals study results of skincare treatment technology

US-based skincare solutions provider Dermaclara has revealed the results of two independent clinical studies conducted to prove the effectiveness of its Silicone Fusion Technology.

Designed for the treatment of stretch marks and wrinkles, Dermaclara’s Silicone Fusion is an anti-ageing skincare treatment technology that is used by Clarafuse’s silicone anti-ageing pads.

BioScreen Testing Services has prepared a final report on the studies, which says the first study found “statistically significant improvements in the appearance of stretch from baseline at day seven post-treatment”.

The second study revealed “significant improvements within one hour of treatment”, confirming the effectiveness of Silicone Fusion Technology in reducing the appearance of fine lines and wrinkles.

Dermaclara brand manager Catherine Nguyen said: “At Dermaclara, we stand behind our claims 100%. Our proven third-party clinical studies offer further endorsement to the effectiveness of our products for our growing network of authorised specialty retailers and estheticians, many of whom experience immediate great product results and brand response with their clientele.”

Dermaclara has also launched the Specialty Retail and Esthetician programme to expand the availability of its Silicone Fusion skincare line.

Nguyen further added: “Our Silicone Fusion Technology offers our partners enhanced revenue opportunities and client engagement, as well as complementing its existing skincare treatments and services.

“We also offer our partners online lead referrals for their territories and marketing assistance.”